US Patent Issued to Wake Forest University Health Sciences on Aug. 25 for "Antibodies against human and canine IL-13RA2" (North Carolina Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,926, issued on Aug. 25, was assigned to Wake Forest University Health Sciences (Winston-Salem, N.C.).

"Antibodies against human and canine IL-13RA2" was invented by Waldemar Debinski (Winston-Salem, N.C.) and Denise Mazess Herpai (Winston-Salem, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are monoclonal antibodies that specifically bind IL-13RA2 with cross-reactivity in humans and canines. Also provided are methods of use of the antibodies in the treatment and monitoring of cancers."

The patent was filed on April 11, 2023, under Application No. 18/298,466.

*For further information, including images, charts and tables, pleas...